Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Symbiosis acquires a 20,000 sq/ft building in Stirling, UK, to house new high-tech medicines manufacturing capacity, financed by £1.2m from Barclays Corporate Bank PLC
Wednesday, October 09, 2024Symbiosis Pharmaceutical Services Ltd Symbiosis a rapidly expanding Contract Manufacturing Organisation CMO and biopharmaceutical development services provider announces the purchase of new premises in Stirling Scotland UK
ScaleReady announces a G-Rex® Grant has been awarded to LIfT Biosciences
Wednesday, October 09, 2024ScaleReady in collaboration with Wilson Wolf Manufacturing BioTechne Corporation and CellReady and LIfT BioSciences a rapidly emerging biotech company about to start clinical trials for its firstinclass allogeneic innate cell therapy today announced...
Pharmanovia Acquires Exclusive Rights to Treatment for Parkinson’s Disease
Tuesday, October 08, 2024Pharmanovia a global pharmaceutical company that commercialises novel medicines and revitalises extends and expands the lifecycle of established medicines has today announced the expansion of its neurology portfolio with a new licensing agreement for...
VIVUS Announces Commercialization of QSIVA® in Sweden, Denmark, Finland, Iceland, Norway, and Poland
Tuesday, October 08, 2024VIVUS BV a subsidiary of VIVUS LLC today announced the availability of QSIVA phentermine and topiramate modifiedrelease in Sweden Denmark Finland Iceland Norway and Poland making QSIVA accessible to patients with overweight and obesity who could bene...
Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA
Tuesday, October 08, 2024Teva Pharmaceutical Industries Ltd today announced that the United States US Food and Drug Administration FDA has accepted and the European Medicines Agency EMA has validated applications for TVBP a biosimilar candidate to Prolia denosumab
New Higher Dose Nusinersen Efficacy and Safety Data Presented at World Muscle Society Congress, Highlight Potential to Maximize Benefit of Nusinersen in SMA
Tuesday, October 08, 2024Biogen Inc today announced detailed results from Part B and Part C of the Phase DEVOTE study evaluating the safety and efficacy of an investigational higher dose regimen of nusinersen in spinal muscular atrophy SMA showing benefits in both individua...
Thermo Fisher Scientific Showcases Expanded Biopharma Services, Capabilities and Innovations at CPHI Milan 2024
Monday, October 07, 2024Thermo Fisher Scientific Inc the world leader in serving science will showcase its latest innovations enabling the moleculetomedicine journey and host a series of sessions that feature industry developments during CPHI Milan Oct in Milan Italy Lead...
BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes
Monday, October 07, 2024BD Becton Dickinson and Company a leading global medical technology company and ten health the humancentric and sustainable strategic CDMO partner of choice for the pharmaceutical industry and biotech startups today announced a collaboration to devel...
Franklin Biolabs Launches to Provide Industry Leading Genetic Medicines CRO Services
Friday, October 04, 2024Franklin Biolabs a new genetic medicines focused contract research organization CRO founded by gene therapy pioneer James Wilson MD PhD marked its first week of operations Franklin Biolabs and its team of over experts offer a full range of service...
Virica Biotech and Ginkgo Bioworks Announce Partnership to Accelerate AAV Gene Therapy Manufacturing
Friday, October 04, 2024Ginkgo Bioworks Inc which is building the leading platform for cell programming and biosecurity and Virica Biotech Inc Virica a leading developer of enhancers for scaling of viral vectors as well as cell and gene therapies today announced a strategic...
